Appendix on transparency rules to the Functional ...
Send a question via our ... Reproduction is authorised provided the source is acknowledged. 2 October 2015 . EMA/228383/2015 Endorsed . Appendix, on disclosure rules, to the “Functional specifications for the EU portal and EU database to be audited - EMA/42176/2014” Draft reviewed with the clinical trials information system expert group . 8 ...
Download Appendix on transparency rules to the Functional ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Management of Ingested Foreign Bodies in Children: A ...
naspghan.orgbecause of specific patient circumstances. Furthermore, additional clinical studies may be necessary to clarify aspects based on expert opinion instead of published data. Thus, these guidelines may be revised as needed to account for new data, changes in clinical practice, or avail-ability of new technology.
A Level Psychology - Edexcel
qualifications.pearson.comFirst teaching from September 2015 First certification from 2017 Issue 2. Pearson Edexcel Level 3 Advanced GCE ... Clinical psychology 24 Topic 6: Criminological psychology 29 Topic 7: Child psychology 34 ... Sections A–D total 70 marks and comprise mixed question types, including
Nasogastric/Orogastric Tube Insertion, Verification, and ...
www.childrensmn.orgiii. If x-ray is obtained for another clinical reason, NG/OG located should be verified. b. In low risk patients and those in the neonatal community i. X-ray is not required for verification of initial tube placement; X-ray may be obtained if there is any question about proper placement, changes in patient condition, or any other concerning ...
Clinical Chemistry
www.corelaboratory.abbottClinical chemistry is the branch of laboratory medicine that focuses primarily on molecules. The tests in a clinical chemistry laboratory measure concentrations of biologically important ions (salts and minerals), small organic molecules and large macromolecules (primarily proteins). See Section 6 for more detail about specific analytes.
Guideline on similar biological medicinal products ...
www.ema.europa.euThe non-clinical section addresses the pharmaco-toxicological assessment. The clinical section addresses the requirements for pharmacokinetic, pharmacodynamic, and efficacy studies. The section on clinical safety and pharmacovigilance addresses clinical safety studies, including immunogenicity, as well as the risk management plan.
POLICE FOUNDATION REPORTS
www.policefoundation.org2. The clinical psychologists™ recommendations that police actively mediate or arbitrate disputes underlying the violence, restoring peace but not making any arrests. 3. The approach recommended by many women™s groups and the Police Executive Research Forum (Loving, 1980) of treating the violence as a criminal offense subject to arrest.